The nonprofit organization presents evidence of strategic thinking and goal setting through sharing their most important strategic goals.
Goal One: Fund and expand research efforts to advance understanding of the drivers of fibrolamellar carcinoma, identify possible therapies, and improve patient outcomes.
Goal Type: New program(s) based on observed changes in needs among our constituencies/communities served.
Goal Two: Drive collaboration and engagement among patients, researchers, clinicians and industry to accelerate research progress, support rapid information sharing and ensure patient-focused results.
Goal Type: This goal reflects our commitment to further our advocacy work for our organization and or cause area.
Goal Three: Provide disease and treatment information to drive awareness of the disease, educate those affected by FLC, and to inform clinicians and researchers of the latest advances in the field.
Goal Type: New program(s) based on observed changes in needs among our constituencies/communities served.